Clinical implications of in silico mathematical modeling for glioblastoma: a critical review Maria ProtopapaAnna ZygogianniVassilis Kouloulias Topic Review 28 October 2017 Pages: 1 - 11
Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics Melissa A. PrahMona M. Al-GizawiyKathleen M. Schmainda Laboratory Investigation 12 September 2017 Pages: 13 - 21
Convection-enhanced delivery of sulfasalazine prolongs survival in a glioma stem cell brain tumor model Shinya HaryuRyuta SaitoTeiji Tominaga Laboratory Investigation 19 September 2017 Pages: 23 - 31
Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients Daniel I. JacobsYanhong LiuMelissa L. Bondy Laboratory Investigation 30 September 2017 Pages: 33 - 39
Overexpression of COX7A2 is associated with a good prognosis in patients with glioma Shengze DengYaomin LiSongtao Qi Laboratory Investigation 27 October 2017 Pages: 41 - 50
A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker Alessandra SantangeloPietro ImbrucèMaria Cristina Dechecchi Laboratory Investigation 26 October 2017 Pages: 51 - 62
MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma Wende LiYujiao LiuPeigen Huang Laboratory Investigation 28 October 2017 Pages: 63 - 71
Development of the Pediatric Neuro-Oncology Rating of Treatment Intensity (PNORTI) Matthew C. HockingWendy HobbieMichael J. Fisher Clinical Study 08 September 2017 Pages: 73 - 78
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02 Phioanh Leia NghiemphuVictoria Asuquo EbianaTimothy F. Cloughesy Clinical Study 07 October 2017 Pages: 79 - 86
Predictors of 30- and 90-day readmission following craniotomy for malignant brain tumors: analysis of nationwide data Daniel A. DonohoTimothy WenFrank J. Attenello Clinical Study 07 October 2017 Pages: 87 - 94
Long-term outcomes of adult medulloblastoma patients treated with radiotherapy Brian DeKathryn BealSuzanne L. Wolden Clinical Study 10 October 2017 Pages: 95 - 104
Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study Roberta RudàAlessia PellerinoRiccardo Soffietti Clinical Study 13 October 2017 Pages: 105 - 114
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma J. DuerinckS. Du FourB. Neyns Clinical Study 07 October 2017 Pages: 115 - 125
Current and emerging treatment strategies for children with progressive chiasmatic-hypothalamic glioma diagnosed as infants: a web-based survey Amedeo A. AziziAntoinette Y. N. Schouten-van Meeteren Clinical Study Open access 25 October 2017 Pages: 127 - 134
Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis Joeky T. SendersNicole H. GoldhaberMarike L. D. Broekman Clinical Study Open access 16 October 2017 Pages: 135 - 145
Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy Waseem MasalhaDieter Henrik HeilandJuergen Grauvogel Clinical Study 28 October 2017 Pages: 147 - 154
Long-term survivors of glioblastoma: a closer look Lucy GatelySue-Anne McLachlanAnthony Dowling Clinical Study 27 October 2017 Pages: 155 - 162
Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer José Pedro LavradorMarta Valente PintoAndré Peralta Santos Clinical Study 08 November 2017 Pages: 163 - 171
Influence of neutrophil–lymphocyte ratio in prognosis of glioblastoma multiforme Marta LopesBruno CarvalhoPaulo Linhares Clinical Study 26 October 2017 Pages: 173 - 180
Preoperative relative cerebral blood volume analysis in gliomas predicts survival and mitigates risk of biopsy sampling error Brendan J. McCulloughValerie AderBart P. Keogh Clinical Study 02 November 2017 Pages: 181 - 188
Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma Iris FriedAlex LossosMony Benifla Clinical Study 15 November 2017 Pages: 189 - 195
The modified frailty index and 30-day adverse events in oncologic neurosurgery Brett E. YoungermanAlfred I. NeugutJeffrey N. Bruce Clinical Study 14 November 2017 Pages: 197 - 206
Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur Dylann FujimotoRie von EybenScott G. Soltys Clinical Study 02 November 2017 Pages: 207 - 212
Hospital volume and group expertise in newly diagnosed glioblastoma management Rimas V. LukasMaciej S. LesniakRoger Stupp Letter to the Editor 07 October 2017 Pages: 213 - 214
Early initiation of chemoradiation may not influence survival of high-grade gliomas Luiz Victor Maia LoureiroSuzana Maria Fleury Malheiros Letter to the Editor 08 November 2017 Pages: 215 - 216
Prognostic effect of neutrophil–lymphocyte ratio during concurrrent chemo-radiotherapy period in glioblastoma patients who did not receive dexamethasone Kadri Altundag Letter to the Editor 31 October 2017 Pages: 217 - 217
Correction to: A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma Sophie E. M. Veldhuijzen van ZantenFatma E. El‑KhoulyGertjan J. L. Kaspers Correction 23 October 2017 Pages: 219 - 220
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study Enrico FranceschiRoberta DepenniThe PERNO Study Group Correction 09 November 2017 Pages: 221 - 222
